Crossmark

Quality of Life (QoL) Among Patients with Esophageal Cancer Using Validated European Organisation for Research and Treatment of Cancer (EORTC)—A Hospital-Based Cross-Sectional Study

Crossref DOI link: https://doi.org/10.1007/s13193-025-02186-y

Published Online: 2025-01-13

Published Print: 2025-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Debnath, Samapti

Harris, Caleb https://orcid.org/0000-0003-0658-7140
S, Shanthosh Priyan

Jagtap, Vikas
Funding

Funding for this research was provided by:

Indian Council of Medical Research (ICMR STS : 2022-09969)
License Information

Text and Data Mining valid from 2025-01-13

Version of Record valid from 2025-01-13
More Information

Article History

Received: 22 July 2024

Accepted: 30 December 2024

First Online: 13 January 2025

Declarations

:

: This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by Institute Ethics Committee (IEC No.: NEIGR/IEC/M4/S1/2022).

: Informed consent was obtained from all individual participants included in the study.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below